270 related articles for article (PubMed ID: 28482391)
21. X-linked lymphoproliferative disease is caused by deficiency of a novel SH2 domain-containing signal transduction adaptor protein.
Schuster V; Kreth HW
Immunol Rev; 2000 Dec; 178():21-8. PubMed ID: 11213803
[TBL] [Abstract][Full Text] [Related]
22. [X-linked lymphoproliferative syndrome, EBV virus infection and defects in cytotoxicity lymphocyte regulation].
Malbrán A; Belmonte L; Ruibal-Ares B; Baré P; Bracco MM
Medicina (B Aires); 2003; 63(1):70-6. PubMed ID: 12673966
[TBL] [Abstract][Full Text] [Related]
23. X-linked lymphoproliferative disease. 2B4 molecules displaying inhibitory rather than activating function are responsible for the inability of natural killer cells to kill Epstein-Barr virus-infected cells.
Parolini S; Bottino C; Falco M; Augugliaro R; Giliani S; Franceschini R; Ochs HD; Wolf H; Bonnefoy JY; Biassoni R; Moretta L; Notarangelo LD; Moretta A
J Exp Med; 2000 Aug; 192(3):337-46. PubMed ID: 10934222
[TBL] [Abstract][Full Text] [Related]
24. Comprehensive molecular diagnosis of Epstein-Barr virus-associated lymphoproliferative diseases using next-generation sequencing.
Ono S; Nakayama M; Kanegane H; Hoshino A; Shimodera S; Shibata H; Fujino H; Fujino T; Yunomae Y; Okano T; Yamashita M; Yasumi T; Izawa K; Takagi M; Imai K; Zhang K; Marsh R; Picard C; Latour S; Ohara O; Morio T
Int J Hematol; 2018 Sep; 108(3):319-328. PubMed ID: 29777376
[TBL] [Abstract][Full Text] [Related]
25. [X-linked lymphoproliferative syndrome type 1 complicated with secondary hemophagocytic lymphohistiocytosis and ileal perforation: case report and literature review].
Xiao L; Guan XM; Meng Y; Zhao XD; Xian Y; An YF; Yu J
Zhonghua Er Ke Za Zhi; 2016 Apr; 54(4):290-3. PubMed ID: 27055430
[TBL] [Abstract][Full Text] [Related]
26. Characterization of SH2D1A missense mutations identified in X-linked lymphoproliferative disease patients.
Morra M; Simarro-Grande M; Martin M; Chen AS; Lanyi A; Silander O; Calpe S; Davis J; Pawson T; Eck MJ; Sumegi J; Engel P; Li SC; Terhorst C
J Biol Chem; 2001 Sep; 276(39):36809-16. PubMed ID: 11477068
[TBL] [Abstract][Full Text] [Related]
27. Diagnostic challenges for a novel SH2D1A mutation associated with X-linked lymphoproliferative disease.
Torralba-Raga L; Tesi B; Chiang SCC; Schlums H; Nordenskjöld M; Horne A; Henter JI; Meeths M; Abdelhaleem M; Weitzman S; Bryceson Y
Pediatr Blood Cancer; 2020 Apr; 67(4):e28184. PubMed ID: 31994322
[TBL] [Abstract][Full Text] [Related]
28. A spectrum of mutations in SH2D1A that causes X-linked lymphoproliferative disease and other Epstein-Barr virus-associated illnesses.
Sumegi J; Seemayer TA; Huang D; Davis JR; Morra M; Gross TG; Yin L; Romco G; Klein E; Terhorst C; Lanyi A
Leuk Lymphoma; 2002 Jun; 43(6):1189-201. PubMed ID: 12152986
[TBL] [Abstract][Full Text] [Related]
29. X-linked lymphoproliferative syndrome presenting with systemic lymphocytic vasculitis.
Kanegane H; Ito Y; Ohshima K; Shichijo T; Tomimasu K; Nomura K; Futatani T; Sumazaki R; Miyawaki T
Am J Hematol; 2005 Feb; 78(2):130-3. PubMed ID: 15682426
[TBL] [Abstract][Full Text] [Related]
30. Analysis of SH2D1A mutations in patients with severe Epstein-Barr virus infections, Burkitt's lymphoma, and Hodgkin's lymphoma.
Parolini O; Kagerbauer B; Simonitsch-Klupp I; Ambros P; Jaeger U; Mann G; Haas OA; Morra M; Gadner H; Terhorst C; Knapp W; Holter W
Ann Hematol; 2002 Aug; 81(8):441-7. PubMed ID: 12224001
[TBL] [Abstract][Full Text] [Related]
31. Expansion of somatically reverted memory CD8+ T cells in patients with X-linked lymphoproliferative disease caused by selective pressure from Epstein-Barr virus.
Palendira U; Low C; Bell AI; Ma CS; Abbott RJ; Phan TG; Riminton DS; Choo S; Smart JM; Lougaris V; Giliani S; Buckley RH; Grimbacher B; Alvaro F; Klion AD; Nichols KE; Adelstein S; Rickinson AB; Tangye SG
J Exp Med; 2012 May; 209(5):913-24. PubMed ID: 22493517
[TBL] [Abstract][Full Text] [Related]
32. SH2D1A mutation analysis for diagnosis of XLP in typical and atypical patients.
Yin L; Ferrand V; Lavoué MF; Hayoz D; Philippe N; Souillet G; Seri M; Giacchino R; Castagnola E; Hodgson S; Sylla BS; Romeo G
Hum Genet; 1999 Nov; 105(5):501-5. PubMed ID: 10598819
[TBL] [Abstract][Full Text] [Related]
33. Mice deficient in the X-linked lymphoproliferative disease gene sap exhibit increased susceptibility to murine gammaherpesvirus-68 and hypo-gammaglobulinemia.
Yin L; Al-Alem U; Liang J; Tong WM; Li C; Badiali M; Médard JJ; Sumegi J; Wang ZQ; Romeo G
J Med Virol; 2003 Nov; 71(3):446-55. PubMed ID: 12966553
[TBL] [Abstract][Full Text] [Related]
34. Impaired Epstein-Barr virus-specific CD8+ T-cell function in X-linked lymphoproliferative disease is restricted to SLAM family-positive B-cell targets.
Hislop AD; Palendira U; Leese AM; Arkwright PD; Rohrlich PS; Tangye SG; Gaspar HB; Lankester AC; Moretta A; Rickinson AB
Blood; 2010 Oct; 116(17):3249-57. PubMed ID: 20644117
[TBL] [Abstract][Full Text] [Related]
35. Clinical and genetic features of 5 Chinese patients with X-linked lymphoproliferative syndrome.
Sun J; Ying W; Liu D; Hui X; Yu Y; Wang J; Wang X
Scand J Immunol; 2013 Nov; 78(5):463-7. PubMed ID: 23944711
[TBL] [Abstract][Full Text] [Related]
36. Deficiency of the proapoptotic SAP function in X-linked lymphoproliferative disease aggravates Epstein-Barr virus (EBV) induced mononucleosis and promotes lymphoma development.
Nagy N; Klein E
Immunol Lett; 2010 May; 130(1-2):13-8. PubMed ID: 20080127
[TBL] [Abstract][Full Text] [Related]
37. Intronic SH2D1A mutation with impaired SAP expression and agammaglobulinemia.
Recher M; Fried AJ; Massaad MJ; Kim HY; Rizzini M; Frugoni F; Walter JE; Mathew D; Eibel H; Hess C; Giliani S; Umetsu DT; Notarangelo LD; Geha RS
Clin Immunol; 2013 Feb; 146(2):84-9. PubMed ID: 23280491
[TBL] [Abstract][Full Text] [Related]
38. Characterization of a new disease-causing mutation of SH2D1A in a family with X-linked lymphoproliferative disease.
Erdõs M; Uzvölgyi E; Nemes Z; Török O; Rákóczi E; Went-Sümegi N; Sümegi J; Maródi L
Hum Mutat; 2005 May; 25(5):506. PubMed ID: 15841490
[TBL] [Abstract][Full Text] [Related]
39. The X-linked lymphoproliferative disease gene product SAP is expressed in activated T and NK cells.
Nagy N; Mattsson K; Maeda A; Liu A; Székely L; Klein E
Immunol Lett; 2002 Jun; 82(1-2):141-7. PubMed ID: 12008045
[TBL] [Abstract][Full Text] [Related]
40. Epstein-Barr virus LMP1 inhibits the expression of SAP gene and upregulates Th1 cytokines in the pathogenesis of hemophagocytic syndrome.
Chuang HC; Lay JD; Hsieh WC; Wang HC; Chang Y; Chuang SE; Su IJ
Blood; 2005 Nov; 106(9):3090-6. PubMed ID: 16002423
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
